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Abstract
Background: Our previous infodemiological study was performed by manually mining health-effect data associated with
electronic cigarettes (ECs) from online forums. Manual mining is time consuming and limits the number of posts that can be
retrieved.
Objective: Our goal in this study was to automatically extract and analyze a large number (>41,000) of online forum posts
related to the health effects associated with EC use between 2008 and 2015.
Methods: Data were annotated with medical concepts from the Unified Medical Language System using a modified version of
the MetaMap tool. Of over 1.4 million posts, 41,216 were used to analyze symptoms (undiagnosed conditions) and disorders
(physician-diagnosed terminology) associated with EC use. For each post, sentiment (positive, negative, and neutral) was also
assigned.
Results: Symptom and disorder data were categorized into 12 organ systems or anatomical regions. Most posts on symptoms
and disorders contained negative sentiment, and affected systems were similar across all years. Health effects were reported most
often in the neurological, mouth and throat, and respiratory systems. The most frequently reported symptoms and disorders were
headache (n=939), coughing (n=852), malaise (n=468), asthma (n=916), dehydration (n=803), and pharyngitis (n=565). In
addition, users often reported linked symptoms (eg, coughing and headache).
Conclusions: Online forums are a valuable repository of data that can be used to identify positive and negative health effects
associated with EC use. By automating extraction of online information, we obtained more data than in our prior study, identified
new symptoms and disorders associated with EC use, determined which systems are most frequently adversely affected, identified
specific symptoms and disorders most commonly reported, and tracked health effects over 7 years.
(J Med Internet Res 2020;22(1):e15684)  doi: 10.2196/15684
KEYWORDS
electronic cigarettes; vaping epidemic; vaping-associated pulmonary illness; e-cigarettes; electronic nicotine delivery devices;
health effects; nicotine; symptoms; disorders; pulmonary disease; pneumonia; headaches; content analysis; text classification;
e-cigarette, or vaping, product use associated lung injury
Introduction
Background
At the time of their introduction 10 years ago, there was little
information on the health effects associated with electronic
cigarettes (ECs); nevertheless, they were often considered safer
than conventional cigarettes because they do not burn tobacco
and therefore produce aerosols with fewer chemicals. Since
their introduction, a wide range of studies concerning the health
effects associated with ECs have been conducted using various
approaches that include online informatics and survey studies
[1-6], short-term physiological assessments of EC use on human
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health [7,8], and in vitro and in vivo cytotoxicity studies [9-15].
Although these studies are limited mainly to acute exposures,
they often suggest that EC use is not harm free [16]. Summaries
of the health effect data and case report information on ECs can
be found in 2 recent reviews [17,18].
Infodemiological approaches, which mine data from the internet
and social media, have yielded new information such as EC
topography and the effects of EC use on human health [1,19-22].
For example, in a previous study, we mined internet data on EC
puffing topography and showed that puff duration is about twice
as long for EC users than conventional smokers [22]. In addition,
topography is highly variable among EC users, who generally
intake much larger volumes of aerosol than cigarette smokers
[23]. In our prior infodemiological study, we mined information
manually from major EC online health forums and identified
numerous negative and some positive health effects that users
attributed to ECs [1]. This was a useful approach; however,
manual mining methods are labor intensive, limit the number
of posts that can be reasonably extracted and analyzed, and are
not practical for examining large amounts of data over time.
Objectives
The objective of this study was to use automated computer
methods to mine an online forum and extract a large set of posts
dealing with the effects of EC use on human health. These data
were analyzed to identify the symptoms (undiagnosed
conditions) and disorders (physician-diagnosed terminology)
associated with EC use. Data were analyzed over a 7-year
period, and the sentiment in each post (positive, negative, and
neutral) was determined.
Methods
Datasets
We collected data posted between January 2008 and July 2015
on a large EC discussion forum. Data from 2008 and 2015 were
each collected for approximately 6 months. We analyzed the
layout of the website and built a crawler in Java using the Java
library jsoup [24], which is designed to extract and parse
information from HTML pages. The posts were collected from
7 subforums. The total number of discussion threads was 2330
and the total number of posts was 1,450,896. As the primary
goal of this study was to evaluate the health effects produced
by ECs, we focused on those posts that belonged to the 7 health
subforums, which contained 41,216 posts. We emphasize that
all collected data are publicly available, including discussion
threads and users’ information. Figure 1 shows the overall
pipeline used for our analysis.
Figure 1. Online forum data pipeline showing processing, post sorting, and classification workflow.
Medical Concepts
We used a modified version of the MetaMap tool [25] to
annotate each post with a set of medical concepts from the
Unified Medical Language System (UMLS). UMLS is a
repository of a large number of biomedical controlled
vocabularies [26]. In UMLS, there are 15 high-level semantic
groups, which were created to help reduce complexity by
grouping the semantic types [27]. In this work, we analyzed 2
semantic types, sign or symptoms and disorder or syndrome,
which belong to the Symptoms and Disorders semantic groups.
Each concept in UMLS can be assigned to multiple semantic
types, but only to 1 semantic group [27]. As MetaMap was built
to annotate the natural language text in biomedical academic
publications, it is not very effective out-of-the-box on social
media posts, as it successfully maps the medical terms most of
the time, and not the descriptive or nonmedical terms [28]. To
improve the tool’s mapping efficiency, we manually examined
and removed misclassified UMLS concepts generated by
MetaMap by performing the following steps:
1. For the 2 semantic types (symptoms and disorders), we
ordered the concepts by their frequencies.
2. We analyzed the different terms mapped to each concept.
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3. We removed the misclassified concepts from our results.
Examples of misclassified concepts include:
a. mod, which refers to vape mods, was mapped to Type
2 diabetes mellitus (C0011860)
b. ect, which is a type of vape mod, was mapped to Benign
Rolandic epilepsy (C2363129)
c. pic was mapped to Punctate inner choroidopathy
(C0730321)
For each semantic type, we reported the most frequent disorders
and symptoms overall and by year.
Sentiment
To measure the positive and negative health effects produced
by EC use, we used a supervised learning classifier (Random
Forest) on a set of manually labeled posts to predict the
sentiment for unseen posts. We randomly selected 1080 posts,
which were labeled independently by 3 of the authors as the
following:
• Negative: if a post clearly contained a health effect or
unpleasant experience or complaint that co-occurred with
the use of EC.
• Positive: if a post clearly mentioned a health improvement
or a recovery from previous health effects when switching
from smoking analogs to EC.
• Neutral: if a post did not express any sentiment.
Our interpretation of positive and negative is different from
typical sentiment classifications, and mainly focuses on
health-related effects. We first asked the labelers to categorize
400 posts, and then we measured the intercoder reliability
between the labelers. Using ReCal [29], an online tool to
calculate the reliability for the masses, the agreement was
80.53% using the Average Pairwise Percent Agreement measure.
Owing to the high agreement, the rest of the posts were split
evenly among the labelers to categorize. Table 1 shows the class
distribution of our sample data with examples for each class;
44.7% (179/400) of posts were labeled as negative, 38.5%
(154/400) as neutral, and 16.7% (67/400) as positive.
Table 1. Sample data summary.
ExamplePosts, nClass
“I’ve only been vaping for 2 1/2 weeks, but I’ve already noticed a big difference in my lungs (after 20+ years of
smoking). For example, I had a chest cold when I started, and in the past, once a cold moved into my chest it took a
couple of months to get rid of it. ...E-cigs are pretty darn amazing, IMHO.” [sic]
180Positive
“I dont [sic] think there are any tests since flavoring were not meant to be inhaled [sic]. I think we are taking our
chances untill [sic] some evidence comes out...”
416Neutral
“Hi Everyone, I have been using e-cigarrette [sic] for the past 2 months and very disappointed [sic] that I have to stop,
reason being my teeth, gums are sensitive and my tooth cracked yesterday, I have to have a crown fitted.8-o [sic]. I
think that the nicotine is seriously not good for the mouth. My husband and work collegue [sic] have also reported
sore gums, little sores in the mouth…”
484Negative
Using Weka machine-learning toolkit v. 3.8.1 [30], we first
filtered our sample data after many experiments using
StringToWordVector class filter, which filters strings into
N-grams using WordTokenizer class, with the following
settings: (1) convert all words to lower case, (2) remove stop
words, (3) stem words using Weka built-in stemmer, (4) keep
only terms that appear at least twice, and (5) retain unigram,
bigram, and trigram. We then split the sample data as follows:
(1) 962 posts for the training test and (2) 118 posts for the test
set. We then trained our data using the Random Forest classifier;
however, the classifier’s initial accuracy was not satisfactory.
To improve the classifier’s accuracy, we needed to address a
well-known issue in our sample data, which is the imbalanced
class distribution [31]. The Positive class, as seen in Table 1,
only covers 16.7% (67/400) of the data, whereas the Neutral
class covers 38.50% (154/400) and the Negative class covers
44.7% (179/400). Thus, we oversampled the Positive class by
duplicating the posts which were labeled Positive in the training
set only. Table 2 shows the new class distribution for the training
set, namely Training (extended). Another approach we used to
improve the accuracy is annotating all the posts in the sample
data with the ancestors of the medical concepts mentioned in
the posts. For example, if pneumonia is mentioned in a post,
then we append with Disorder of lung.
After using the new training set, the classifier’s accuracy
increased from 66.95% to 75.42%. Table 3 reports for each
class 3 different measures, including precision, recall, and
F-measure. As seen in the table, the classifier is most accurate
on the Negative class (F-measure=0.79), followed by Positive
and Neutral classes.
Table 2. Training data summary (N=400).
Training (extended), n (%)Training, n (%)Class
112 (28.0)67 (16.75)Positive
136 (34.0)154 (38.50)Neutral
152 (38.0)179 (44.75)Negative
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Table 3. Test data classification accuracy (N=118).
Posts, nF-measureRecallPrecisionClass
210.740.720.73Positive
390.710.770.67Neutral
580.790.740.84Negative
1180.760.750.76Average
Data Categorization and Analysis
All health-related effects (symptoms and disorders) data reported
by EC users in posts were collected iteratively and sorted into
Microsoft Excel spreadsheets. The symptoms and disorders
were further grouped according to the organ system and
anatomical region, which we defined as systems previously [1].
When a symptom could have been associated with more than
1 system, the health effect was assigned to the system for which
it had the strongest fit (eg, improved sense of taste was assigned
to sensory but could have been mouth/throat). Frequency
distributions for the overall grouped data in each system for
symptoms and disorders were plotted using GraphPad Prism
(GraphPad, San Diego). In addition, the sentiment for each post
was grouped according to their positive, neutral, and negative
sentiment as described in the Methods section.
Results
Overall Frequency of Reported Symptoms and
Disorders Classified by System or Anatomical Region
The 41,216 posts we collected spanned the years from 2008 to
2015 (2008 and 2015 were half years). We analyzed the
frequency of reports for various symptoms and disorders by
consolidating the reported health effects into structural or
physiological systems (eg, sore throat was classified into mouth
and throat; Figure 2). The 5 systems that had the most reports
for symptoms were neurological (n=3623), respiratory (n=1995),
digestive (n=1637), mouth and throat (n=1390), and
integumentary (n=853; Figure 2). The top 5 systems for
disorders were respiratory (n=2972), mouth and throat (n=1986),
neurological (n=1143), integumentary (n=1123), and immune
(n=739; Figure 2). For both symptoms and disorders, a majority
of the posts were associated with negative sentiment across all
systems (Figure 2).
Figure 2. Frequency distribution of reported symptom (A) and disorder (B) posts grouped into their systems or anatomical regions. The frequency of
positive, neutral, and negative posts is shown for symptoms (A) and for disorders (B).
Symptom and Disorder Frequency and Sentiment
Distribution Over Time
After examining overall frequency distribution for all posts, we
grouped the posts according to their years for analysis in their
symptom or disorder categories. Across all years for both
symptoms and disorders, we found the frequency distribution
of reports per year. In addition, the posts for symptoms and
disorders were categorized according to sentiment (positive,
negative, and neutral), and their frequency per year was
summarized in stacked bar graphs for each year (Figure 3).
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Figure 3. The frequency distribution of positive, neutral, and negative sentiment was assigned for reported symptoms (A-H) and disorders (I-P).
For the symptoms, the posts with the most reports were
consistently found in the neurological, respiratory, digestive,
integumentary, and mouth and throat systems. For all years
except 2008, the neurological and respiratory systems were the
top 2 systems. The digestive, integumentary, and mouth and
throat alternated in some years, but were generally in the top 5
systems with the most posts in each of the years.
Similarly, the posts containing disorders associated with EC
use had similar results for their top 5 system categories across
the 7 years of reporting. The 2 top systems reported between
2008 and 2012 were the respiratory and mouth/throat.
Alternating in the top 5 disorders were the integumentary,
neurological, and immune systems.
Negative sentiment was associated with most symptoms and
disorders in each system or anatomical region (Figure 3), with
some increases reported in positive health effects in 2015 for
the disorders (Figure 3). It should also be noted that we only
J Med Internet Res 2020 | vol. 22 | iss. 1 | e15684 | p. 5https://www.jmir.org/2020/1/e15684
(page number not for citation purposes)
Hua et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
have partial reporting for 2015 because data collection was
terminated by the EC forum.
Specific Symptoms and Disorders in Systems With the
Most Reports
Heat maps were made by plotting the frequency with which
individual symptoms/disorders occurred for all 41,216 posts
(Figures 4 and 5; Multimedia Appendices 1 and 2). Symptoms
with fewer than 2 posts are listed in Multimedia Appendix 3.
The total number of negative and positive posts for each
symptom or disorder is shown on a log scale ranging from high
(red) to low (blue). White represents a zero-post frequency.
Numerous negative symptoms were reported for each system.
Typically, about 16.52% (6807/41,216) of the symptoms were
reported frequently (red), while the majority often occurred in
fewer than 100 posts (blue to purple). In the neurological system,
the most common symptoms included: headaches (n=939),
fatigue/tired/malaise (n=468), nausea (n=290), dizziness
(n=183), and lightheadedness (n=113; Figure 4). In the
respiratory system, the negative effects included: coughing
(n=852), wheezing (n=298), dyspnea (n=235), and excessively
deep breathing (n=112). The most reported symptoms in the
digestive system were: heartburn (n=327), cramping (n=303),
flatus (n=176), and constipation (n=113). In the mouth/throat
and integumentary systems, common symptoms were: pain in
throat (n=643), harsh voice quality (n=175), pharyngeal dryness
(n=147), itching skin (n=565), and dry skin (n=121; Figure 4).
Other commonly reported symptoms involved aching and chest
pains as well as immune symptoms related to the cold and flu.
Although positive symptoms were not frequently reported in
this online forum, those reports that were posted most often
dealt with improvements in the neurological (n=77), respiratory
(n=60), digestive (n=19), and mouth and throat (n=18) systems
(Figure 4). In the neurological system, these include
improvement in tiredness (n=12) and insomnia (n=8). For
respiratory system, these symptoms included improvements in
wheezing (n=17), dyspnea (n=14), and coughing (n=8). In the
digestive and mouth and throat systems, improvements were
found in cramp (n=5) and halitosis (n=5). Other systems and
anatomical regions had fewer than 10 total positive reports.
For each system/anatomical region, there were 1 to 3 top
disorders. In the respiratory system, the most common disorders
were asthma (n=916), chronic obstructive pulmonary disorder
(COPD; n=471), pneumonia (n=367), and bronchitis (n=232;
Figure 5). In mouth and throat, the most common disorders
were pharyngitis (n=565), aptyalism (n=377), and ulcer of mouth
(n=207). The most reported disorders in the neurological system
were dehydration (n=403) and migraine (n=103). Most disorders
were reported in the respiratory, mouth and throat, neurological,
integumentary, and immune systems (Figure 5), whereas the
remaining systems had fewer reported disorders (Multimedia
Appendix 2).
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Figure 4. Heat map of specific symptoms reported in the neurological, respiratory, digestive, mouth and throat, and integumentary systems. The total
number of posts for each symptom is shown on a log scale ranging from high (red) to low (blue).
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Figure 5. Heat map of specific disorders reported in the respiratory, mouth and throat, neurological, integumentary, and immune systems. The total
number of posts for each disorder is shown on a log scale ranging from high (red) to low (blue).
To compare the frequency with which different
symptoms/disorders appeared across different systems,
frequency distribution graphs were created (Figures 6 and 7).
Graphs show only those symptoms/disorders with over 100
posts (Figures 6 and 7). These data were sorted by negative
sentiment as negative effects were most commonly reported
and were of most interest. In total, 25 symptoms and 22
disorders had over 100 posts. The 5 top symptoms in the 41,216
posts were: headache, coughing, pain in throat, itching, and
malaise (Figure 6). The top 5 disorders in the dataset were
dehydration, asthma, pharyngitis, common cold, and aptyalism
(Figure 7). These symptoms and disorders are the most
commonly reported conditions in our dataset.
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Figure 6. Frequency distribution of specific symptoms with over 100 posts and frequency distribution of their systems or anatomical regions (inset).
Digest.: digestive; Integ.: integumentary; Mo./Th.: mouth and throat; Musc./Skel.: muscular/skeletal; Neuro.: neurological; Resp.: respiratory.
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Figure 7. Frequency distribution of specific disorders with over 100 posts and frequency distribution of their systems or anatomical regions (inset).
Neuro.: neurological; Resp.: respiratory; Mo./Th.: mouth and throat; Integ.: integumentary; Digest.: digestive; Circ.: circulatory; Endoc.: endocrine.
Identification of Frequently Reported Paired
Symptoms
A total of 46 paired symptoms were frequently reported (Figure
8; Multimedia Appendix 4). Those with over 30 reports included
a combination of neurological-neurological symptoms (eg,
nausea and headache), respiratory-respiratory symptoms (eg,
wheezing and coughing), and/or neurological-respiratory-mouth
and throat symptoms (eg, pain in throat and headache; coughing
and headache). The results in the top symptom pairings reflect
the abundance of symptoms reported in their respective
categories. As for those pairings occurring in less than 30 posts,
various combinations of neurological, respiratory,
integumentary, and digestive related symptoms.
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Figure 8. Graph showing frequency with which symptoms in various systems were linked. Digest.: digestive; Integ.: integumentary; Mo./Th.: mouth
and throat; Musc./Skel.: muscular/skeletal; Neuro.: neurological; Resp.: respiratory.
Discussion
Principal Findings
The internet is a dynamic resource containing information that
can be mined to learn about the health effects associated with
EC use. In our previous study, we manually mined 632 posts
from 3 online EC forums to identify both positive and negative
health effects reported by EC users [1]. Manual mining of such
information is time consuming, labor intense, and limited by
the number of posts that can be realistically evaluated. To take
additional advantage of the internet as a repository of EC-related
health information, we developed an automated method that
was used to extract over 1 million posts from an EC forum.
These posts were then filtered to yield over 41,000 health-related
posts for detailed analysis. By automating the extraction process,
we collected 100 times more posts for analysis and tracked
responses over 7 years, an option that would be too time
consuming to perform manually. The data showed a variety of
positive and negative symptoms/disorders, demonstrating that
the internet is a valuable resource for acquiring new data related
to EC usage and their associated health effects.
The results from this study are in overall good agreement with
our prior publication [1]. In both studies, the neurological and
respiratory systems were most often reported to have adverse
effects associated with EC use. Both studies reported similar
positive and negative health effects in various systems, and
within all systems, a small number of self-reported symptoms
and disorders occurred at high frequency (Figures 6 and 7).
However, with the power of automated mining, we were also
able to (1) identify numerous symptoms and disorders, many
of which were not previously reported, along with their
frequencies; (2) report new data in the disorders category for
each system; (3) identify those symptoms/disorders that users
have reported most frequently which will be of interest to health
care providers treating patients using EC products; (4) show
that health effects were similar over a 7-year period; (5) evaluate
positive and negative sentiments for symptoms and disorders;
(6) evaluate symptoms that are linked to each other; and (7)
identify top symptoms (eg, wheezing) and disorders (eg, asthma,
COPD, and pharyngitis) that are associated with inflammation.
In addition, some symptoms (eg, headache and nausea) and
disorders (eg, pneumonia) that occurred with the highest
frequency in the neurological and respiratory system have also
appeared in a number of case reports in the EC literature
[17,32-35]. Also, in agreement with our prior study, some
reported health outcomes attributed to EC use were positive [1].
These included reduction in symptoms such as coughing and
wheezing and disorders such as asthma, COPD, and common
cold. It is very likely that there were real health benefits for
some individuals, especially for those switching from
conventional to EC use, and this is supported by other
publications [36-38].
There are numerous reports on the health effects of EC, many
of which are in agreement with our data. In the neurological
system, the most commonly reported adverse symptoms we
observed included headache, fatigue, nausea, dizziness, and
seizures, which have also been reported in human studies
[39-42]. Headaches have been reported to the Food and Drug
Administration (FDA) by EC users [43], they were a common
side effect in various surveys and online studies [4,44-46] and
were reported in human studies in which participants used
different EC devices and refill fluids with varying nicotine
concentrations [47-49]. In 1 case report, an adult male
experienced severe headaches/migraines and seizures for 1 week
before being diagnosed with reversible cerebral vasoconstriction
syndrome related to EC use [32], and in a second case, an
adolescent female developed persistent daily headaches after a
single EC use [50]. Nausea and dehydration were commonly
reported symptoms and disorders of the neurological system.
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These symptoms have been associated with headache and
fatigue/tiredness [51-54]. In our study, headache and nausea
were frequently reported together, demonstrating that symptoms
associated with EC use may be linked. The frequency
distribution showing symptoms and disorders with over 100
posts also revealed that digestive symptoms such as heartburn
and circulatory disorders such as myocardial infarction were
highly reported. Digestive symptoms related to EC use have
not been previously focused on and may be important to pay
attention to, and disorders such as myocardial infarction
associated with EC have recently received more attention from
epidemiology studies [55].
For the respiratory system, the most frequently reported
symptoms included coughing, wheezing, and dyspnea, and the
top paired respiratory symptoms were coughing-wheezing. In
the national Population Assessment of Tobacco Health (PATH)
and in some human surveys, EC use was associated with
increased wheezing (an important potential risk factor for
respiratory disease) [56-59]. In our study, the top disorders were
asthma, COPD, pneumonia, bronchitis, and sinusitis, which
have a common theme of inflammation. Human studies and
surveys have shown that adolescents and adults associated
chronic bronchitis symptoms (eg, cough, phlegm, or dyspnea)
with EC use [57,58]. Epidemiological studies have linked EC
use to both COPD and asthma [56], and the PATH study showed
that dual use of EC and conventional cigarettes aggravated this
risk [56]. Frequently reported respiratory disorders in our study
such as pneumonia and bronchitis have appeared in several EC
case reports, most of which deal with lung inflammation and
pneumonia-linked incidents [34,35,60,61]. Some of the patients
in these case reports had no preexisting health conditions but
presented with coughing, wheezing, and dyspnea. They typically
recovered from their respiratory disorders after discontinuing
EC use.
The circulatory, mouth/throat, chest, integumentary, and
immunological systems were also affected by EC use in our
study. Symptoms such as pain in throat, dry skin, pounding
heart, and chest pain have been reported in survey/human EC
studies [62]. Myocardial infarction, which was a top disorder
for the circulatory system in our data, has been described in a
case report after the patient used an EC with high nicotine [63].
A link between EC use and myocardial infarction was also found
in a recent national survey adjusted for conventional smoking
and other risk factors [55]. EC users are potentially susceptible
to periodontal disease and increased plaque formation, which
could lead to dental caries (also reported in our paper) [64].
Other reported disorders in our study, such as common cold
and diabetes mellitus, are immunologically based, and multiple
studies have shown EC aerosol exposure can induce
inflammatory response [65]. Mice exposed to EC aerosol have
impaired pulmonary viral and bacterial clearance ability that
can lead to increased bacterial resistance, implying that EC users
are more susceptible to cold and flu, a common complaint in
our online studies. Experimental studies have further
demonstrated that EC aerosol exposure can result in oxidative
stress [13,66,67], suggesting chronic use could trigger
inflammation, leading to progressive inflammatory disorders
in the respiratory system.
Electronic Cigarette Aerosol Chemicals That May
Produce Adverse Health Effects
EC refill fluids and aerosols are complex mixtures that contain
flavor chemicals, solvents, nicotine, and metals that could
contribute to adverse health effects (Table 4). Although most
flavor chemicals in EC are generally regarded as safe (GRAS)
for ingestion, their inhalation safety has usually not been
established [68]. Some EC products contain high concentrations
of flavor chemicals that exceed the National Institute of
Occupational Safety and Health limits [69-75] and the
concentrations normally used in consumer products [71,72].
Many EC flavor chemicals are classified as irritants [72] and
are cytotoxic when tested in vitro at concentrations below those
in EC products [71,72]. Cinnamaldehyde, which is used in refill
fluids including those that do not have cinnamon in their name
[10], is highly cytotoxic in the 3-(4,5-dimethylthiazol-2-yl)
-2,5-diphenyltetrazolium bromide [10,69] and impaired
respiratory response in immunological assays [76-78] and in
vivo assays. In cell, animal, and human studies, EC flavor
chemicals (eg, citrus/fruit and chocolate) caused an increase in
reactive oxygen species leading to tissue and DNA damage and
inflammation [67], which could in turn lead to mutations and
disease progression. Some flavor chemicals, such as alcohols
and phenols, can dilate blood vessels and cause headache,
nausea, and fatigue. Prolonged inhalation of flavor chemicals,
such as benzaldehyde, ethyl butanoate, diacetyl and its
derivatives (2,3-pentadione, acetoin), triacetin, and limonene
can elicit headaches, dizziness, and/or respiratory symptoms.
Diacetyl (2,3-butanedione), a diketone associated with
respiratory symptoms (wheezing and shortness of breath) and
bronchiolitis obliterans, is in some EC refill fluids and can form
as a reaction product during aerosolization [70,74]. Additional
reaction products that form in EC aerosols (eg, aldehydes,
acetals, and oxides) can be harmful to humans and elicit various
symptoms, including pain.
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Table 4. Examples of chemical components in electronic cigarettes that may cause major symptoms/disorders with reference citations of studies.
Nicotine (study)PGa/VGb/byproducts (study)Metals (study)Flavor chemicals (study)SystemSymptom/disorder
[86-88][51,52,84,85][81-83][79,80]NeurologicalHeadache
—
—
c[90][89]NeurologicalFatigue/malaise
[94]—[92,93][91]NeurologicalDizziness
[87,96][85,95][92][79,80]NeurologicalNausea
[97][52,84]——NeurologicalDehydration
—[101,102][62][91,98-100]RespiratoryCoughing
—[104][103][57,99]RespiratoryWheezing
[108][107][105,106][99]RespiratoryDyspnea
—[110][92,103,104][99,109]RespiratoryAsthma
—[110][92][111]RespiratoryCOPDd
——[103]—RespiratoryPneumonia
——[113][111,112]RespiratoryBronchitis
—[114][115][79,114]RespiratorySinusitis
[87][101]——Mouth and throatPain in throat
[118]—[117][116]Mouth and throatDental caries
[123][122][119-121]—IntegumentaryItching/urticaria
—[124]——IntegumentaryDry skin
[126,127]—[125]—IntegumentaryAcne
[128]———DigestiveHeartburn
——[129]—DigestiveCramp
aPG: propylene glycol.
bVG: vegetable glycerin.
cLack of evidence in referenced literature.
dCOPD: chronic obstructive pulmonary disorder.
Elements/metals (eg, aluminum, copper, cadmium, chromium,
iron, nickel, silicon, lead, cobalt, and zinc) have been identified
in EC aerosols [130,131]. In studies not involving ECs, these
elements/metals have been linked to neurological (headache,
nausea, and dizziness) and respiratory (eg, coughing, wheezing,
shortness of breath, and bronchial/pulmonary irritations
impairment) symptoms [132]. A positive correlation has been
reported between human EC use and internal concentrations of
nickel and chromium [133]. We found pneumoconiosis due to
silica frequently reported by users, which could be caused by
silica particles in EC aerosols [130]. Inhalation of silicon
particles can elicit cough, inflammation, and lung fibrosis [134].
Although there is not a consensus on whether element/metal
concentrations in EC aerosols are high enough to produce these
effects [135], some evidence suggests that they could be a factor
[130,136]. A female patient with no history of allergic disease
tested positive for nickel allergy after being diagnosed with
dermatitis caused by corrosion of the EC device [119]. Some
of the top symptoms and disorders in our study also relate to
inflammation of the skin (eg, itching and eczema), and this may
be attributed to direct exposure and allergic reactions to EC
products [119,120].
Propylene glycol and glycerin, 2 solvents in EC aerosols, are
generally considered safe for ingestion; however, they are known
respiratory tract and integumentary irritants [137]. When heated,
propylene glycol can produce toxic aldehyde reaction products,
such as acetaldehyde and formaldehyde [138], which can cause
cellular and tissue damage in the body [67]. Inhalation of
aldehyde fumes can cause dizziness, nausea, and headaches in
humans [113], and formaldehyde can cause coughing, wheezing,
pneumonia, bronchitis, and neurological and cardiovascular
symptoms (eg, headaches, nausea, heart palpitations) [139].
Inhalation of propylene glycol mists can elicit both neurological
and respiratory symptoms, such as nausea, wheezing, shortness
of breath, and cough [101,140] and can exacerbate asthma
[101,140]. Propylene glycol and glycerin produce 15 different
aerobic thermal degradation products through hydrogen
abstraction, oxidation, and cleavage reactions [138]. Several of
these (eg, formaldehyde, formic acid, acetaldehyde, and
acrolein) are carcinogens or have genotoxic potential [141,142].
Some of these byproducts are hemiacetals (such as formic acid
and formaldehyde), which equilibrate and persist in the aerosols
inhaled by the users.
Nicotine, a major component in most EC fluids, has various
neurological, respiratory, digestive, mouth/throat, and circulatory
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system effects that overlap the symptoms/disorders observed
in our study. Most cases of EC nicotine poisonings result from
oral ingestion or intravenous injection [17] and are characterized
by symptoms such as vomiting, nausea, dizziness, headaches,
and more severe effects that can lead to death. The side effects
of nicotine inhalation include headache, nausea, mouth/throat
pain, cough, and heartburn [143]. Some users in our study may
have been weaning themselves off nicotine or using devices
with poor nicotine delivery leading to nicotine withdrawal,
which could produce symptoms such as dizziness and anxiety
[144]. Nicotine can trigger a dose-dependent loss of the
endothelial barrier which has been shown to rapidly increase
lung inflammation and oxidative stress in mice [15]. Nicotine
in EC aerosols can induce glucose deprivation in the brain,
which could lead to enhanced ischemic brain injury and or stroke
risk. In addition, EC refill fluids may contain free-base nicotine
(a form more addictive) [145], which can lead to greater
deposition in the mouth and throat and upper respiratory tract
[146].
Recently, an e-cigarette, or vaping, product use associated lung
injury (EVALI) epidemic has been identified by the Centers for
Disease Control and Prevention (CDC) [147]. As of December
2019, at least 2409 cases of lung injury have been reported to
the CDC from 50 states, the District of Columbia, and 2 US
territories [147]. In addition, 52 deaths associated with vaping
were confirmed by 26 states and the District of Columbia [147].
Some of the commonly reported symptoms in presenting patients
included chest pain, shortness of breath, cough, nausea,
vomiting, diarrhea, fever, chills, fatigue/malaise, and headache
[148-150], all of which are reported in this study. In addition
to lung-related disease, some case reports included neurological
and gastrointestinal symptoms [148,150], which overlap those
found in our study.
The sudden uptick in health-related symptoms and conditions
related to vaping comes at least 10 years after the products have
gained widespread popularity in the United States, including
the rise in popularity of JUUL and marijuana (THC) vape
products. Our data show that many of the symptoms
characterizing the current patients have been reported online
for at least 7 years, suggesting that cases similar to those in the
current epidemic have existed previously and been unreported
or not linked to vaping. Our data further suggest that this
epidemic will continue to grow given the many reports of
symptoms characteristic of EVALI on the internet. The specific
causes of the reported health effects are not yet known, but it
is important to continue vigilant reporting of cases, tracking
symptoms, and ongoing research on the health effects related
to EC use to understand and contain the vaping epidemic.
Limitations
Our data may underestimate positive health effects, which EC
users are less likely to post on online forums. The factors
causing the symptoms and disorders reported by EC users could
be complex and will require further investigations. Demographic
data on the study population were not extractable. It is not
known if any individuals were dual users or if they had
preexisting health conditions that may have affected their
response to EC.
Conclusions
This study is the first to use automated methods to analyze posts
on an EC website over a span of 7 years and to identify the
symptoms and disorders most frequently reported online by EC
users. We demonstrate the value of using automated methods
to acquire and analyze large datasets thereby increasing the
power of infodemiological analyses. In addition, from our
dataset, we identified a condensed list of symptoms and
disorders and ranked them according to post frequency. These
symptoms and disorders reported in our study may be of interest
to physicians and health care providers who are treating patients
using EC and could potentially be reported more frequently by
EC users. Moreover, informative data were collected from a
large population of EC vapers irrespective of their EC products
and individual topographies and was not limited to a small
selection of EC products or human subjects, as is often the case
with experimental studies and case reports. Data collected using
our automated method contribute to the growing body of
knowledge linking EC use to adverse health effects, mainly in
the mouth and throat and the neurological, respiratory, digestive,
and integumentary systems. Our study identified hundreds of
negative effects that were not previously described in case
reports and peer-reviewed literature. The results from our study
are in good agreement with previous surveys, human studies,
and case reports. Although many of the symptoms that were
reported with high frequency are not life-threatening (eg,
headache, coughing, heartburn, sore throat), they can be
disabling and reduce the quality of life. Of particular concern
are the respiratory disorders that appeared with high frequency,
such as asthma, COPD, pneumonia, and bronchitis, which not
only severely impact the quality of life but may also be life
threatening. Our data support the idea that EC use is not free of
adverse health effects and that it is important to continue
tracking the health of EC users. Advances in internet data mining
provide a novel method for monitoring the health of EC users
over time. Infodemiological data gathered on EC users will be
valuable to physicians, regulatory agencies, and the users
themselves.
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